Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1

Biochemical and Biophysical Research Communications

Volumn 403, Issue 1, 2010, Pages 97-102

  Valiyaveettil, Manojkumar ^a   Alamneh, Yonas ^a   Biggemann, Lionel ^a   Soojhawon, Iswarduth ^a   Doctor, Bhupendra P ^a   Nambiar, Madhusoodana P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Catalytic bioscavenger; Chemical warfare nerve agents; Medical chemical defense; Paraoxonase 1; Prophylaxis; Tabun

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE 1; SARIN; SOMAN; TABUN;

ARTICLE; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME PURIFICATION; HUMAN; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; HYDROLYSIS; NERVOUS SYSTEM; PHOSPHORIC ACID ESTERS; RABBITS; RECOMBINANT PROTEINS;

ORYCTOLAGUS CUNICULUS;

EID: 78649688661     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.125     Document Type: Article

References (29)

1. Holstege C.P., Kirk M., Sidell F.R. Chemical warfare. Nerve agent poisoning. Crit. Care Clin. 1997, 13:923-942.
2. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38:151-216.
3. Koplovitz I., Stewart J.R. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit. Toxicol. Lett. 1994, 70:269-279.
4. Worek F., Kirchner T., Backer M., Szinicz L. Reactivation by various oximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol. 1996, 70:497-503.
5. Kassa J., Kuca K., Karasova J., Musilek K. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun. Mini Rev. Med. Chem. 2008, 8:1134-1143.
6. Jokanovic M., Maksimovic M., Kilibarda V., Jovanovic D., Savic D. Oxime-induced reactivation of acetylcholinesterase inhibited by phosphoramidates. Toxicol. Lett. 1996, 85:35-39.
7. Lenz D.E., Maxwell D.M., Koplovitz I., Clark C.R., Capacio B.R., Cerasoli D.M., Federko J.M., Luo C., Saxena A., Doctor B.P., Olson C. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem. Biol. Interact. 2005, 157-158:205-210.
8. Doctor B.P., Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem. Biol. Interact. 2005, 157-158:167-171.
9. Allon N., Raveh L., Gilat E., Cohen E., Grunwald J., Ashani Y. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci. 1998, 43:121-128.
10. Stevens R.C., Suzuki S.M., Cole T.B., Park S.S., Richter R.J., Furlong C.E. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl. Acad. Sci. USA 2008, 105:12780-12784.
11. Josse D., Masson P. Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity. Ann. Pharm. Fr. 2001, 59:108-118.
12. Rochu D., Chabriere E., Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007, 233:47-59.
13. Costa L.G., Cole T.B., Furlong C.E. Paraoxonase (PON1): from toxicology to cardiovascular medicine. Acta Biomed. 2005, 76(Suppl. 2):50-57.
14. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase polymorphisms and coronary heart disease. Lancet 2004, 364:579-580.
15. Costa L.G., Cole T.B., Vitalone A., Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin. Chim. Acta 2005, 352:37-47.
16. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 1996, 14:334-336.
17. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998, 394:284-287.
18. Otto T.C., Harsch C.K., Yeung D.T., Magliery T.J., Cerasoli D.M., Lenz D.E. Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. Biochemistry 2009, 48:10416-10422.
19. Hoskin F.C. Diisopropylphosphorofluoridate and Tabun: enzymatic hydrolysis and nerve function. Science 1971, 172:1243-1245.
20. Wang Q., Sun M., Zhang H., Huang C. Purification and properties of soman-hydrolyzing enzyme from human liver. J. Biochem. Mol. Toxicol. 1998, 12:213-217.
21. Little J.S., Broomfield C.A., Fox-Talbot M.K., Boucher L.J., MacIver B., Lenz D.E. Partial characterization of an enzyme that hydrolyzes sarin, soman, tabun, and diisopropyl phosphorofluoridate (DFP). Biochem. Pharmacol. 1989, 38:23-29.
22. Billecke S.S., Primo-Parmo S.L., Dunlop C.S., Doorn J.A., La Du B.N., Broomfield C.A. Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chem. Biol. Interact. 1999, 119-120:251-256.
23. Rodrigo L., Mackness B., Durrington P.N., Hernandez A., Mackness M.I. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem. J. 2001, 354:1-7.
24. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabol. Dispos. 1991, 19:100-106.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
26. Ellman G.L., Courtney K.D., Andres V., Feather-stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-95.
27. Ahmad S., Carter J.J., Scott J.E. A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity. Anal. Biochem. 2010, 400:1-9.
28. Li W.F., Furlong C.E., Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 1995, 76:219-226.
29. Furlong C.E., Richter R.J., Seidel S.L., Costa L.G., Motulsky A.G. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal. Biochem. 1989, 180:242-247.